Sanjivani Paranteral LtdQ3 FY24
Sanjivani Paranteral Ltd Q3 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹146P/E: 24.0Market Cap: ₹197 CrSector: Pharmaceuticals & Biotechnology
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
No information is provided regarding the same in the latest conference call.
Margin guidance
No information is provided regarding the same in the latest conference call.
3 more insights locked — sign up free to unlock
Fundraise plans
No information is provided regarding the same in the latest conference call.
Order book
No information is provided regarding the same in the latest conference call.
Capex plans
No information is provided regarding the same in the latest conference call.
How does Sanjivani Paranteral Ltd rank vs peers in Pharmaceuticals & Biotechnology?
Pro feature1Sanjivani Paranteral Ltd
See full Pharmaceuticals & Biotechnology sector rankings